Диссертация (1173320), страница 28
Текст из файла (страница 28)
Cockcroft, J. Deanfield [еt al.] // J. Hypertension. – 2005. – Vol. 23(2).– P. 233-246.151.Castejon A.M. Alpha-adducin polymorphism, salt sensitivity, nitric oxideexcretion, and cardiovascular risk factors in normotensive Hispanics / A.M.Castejon, A.B. Alfieri, I.S. Hoffmann [et al.] // American Journal of Hypertension. –2003. – Vol. 16, № 12. – P. 1018-1024.152.Castellano M. Angiotensin II type 1 receptor A/C 1166 polymorphism.Relationships with blood pressure and cardiovascular structure / M.
Castellano, M.L.Muiesan, M. Beschi [et al.] // Hypertension. – 1996. – Vol. 28, № 6. – 1076–1080.153.Cheng X. Association between aldosterone synthase CYP11B2 polymorphismand essential hypertension in Chinese: a meta-analysis /X. Cheng, G. Xu // KidneyBlood Press. Res. – 2009. –Vol. 32, № 2. – Р.128-140.154. Cusi D. Polymorphisms of alpha-adducin and salt sensitivity in patients withessential hypertension / D. Cusi, C.
Barlassina, T. Azzani [et al.] // Lancet. – 1997. –№ 349(9062). – P.1353-1357.155.Dahlov B., for the ASCOT investigators. Prevention of cardiovascular eventswith an antihypertensive regimen of amlodipine adding perindopril as requiredversus atenolol adding bendroflumethiazide as required, in the Anglo-ScandinavianCardiac Outcomes Trial-Blood PressureLowering Arm (ASCOT-BPLA): amulticentre randomized controlled trial / В. Dahlov, P.S. Sever, N.R.
Poulter //Lancet. – 2005. – Vol. 366. – P. 895-906.156. DASH-Sodium Collaborative Research Group. Effects on blood pressure ofreduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH)diet // N. Engl. J. Med. – 2001. – Vol. 344. – P. 3.186157. Delles C. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associatedwith left ventricular structure in human arterial hypertension / C. Delles, J.
Erdman,J. Jacobi [et al.] //J. Am. College Cardiology. – 2001. –Vol. 37, № 3. – P. 878-884.158. Deng AY. Genetic basis of polygenic hypertension / AY. Deng // Humanmolecular genetics. –2007. – Vol. 16(2). – P. 195-202.159. DevereuxR.B.Echocardiographichypertrophy: comparisontoassessmentnecropsyofleftventricularfindings/R.B. Devereux, D.R. Alonso, E.M. Lutas [et al.] // Am J. Cardiol. –1986. –56. –P. 450-458.160.Diez J. The A1166C polymorphism of the AT1 receptor gene is associated withcollagen type I synthesis and myocardial stiffness in hypertensives / J.
Diez, C.Laviades, J.Orbe [et al.] // J. Hypertens. – 2003. –Vol. 21, № 11. –P. 2085–2092.161. Dzau V. Resolved and unresolved issues in the prevention and treatment ofcoronary artery disease: a workshop consensus statement / V. Dzau, E. Braunwald //Am Heart J. –1991. – Vol. 121(4 Pt 1). – P.1244–63.162. Dzida G. Polymorphisms of angiotensin-converting enzyme and angiotensin IIreceptor type 1 genes in essential hypertension in a Polish population / G.
Dzida,J.Sobstyl, A. Puzniak [et al.] // Medical science monitor : international medicaljournal of experimental and clinical research . – 2001. – Vol. 7, № 6. –P. 1236-41.163. Ehret G.Bl. Replication of the Wellcome Trust genome-wide association studyof essential hypertension: the Family Blood Pressure Program / G.B. Ehret, A.C.Morrison, A.A. O’Connor [et al.] // Eur.
J. Hum Genet. – 2008. – № 16(12). – P.1507-1511.164. Fernandez-Arcas N. Both allelles of the M235T polymorphism of theangiotensinogen gene can be a risk factor for myocardial infarction / N. FernandezArcas , J.L. Dieguez-Lucena, E. MunozMoran [et al.] // J. Clinical Genetics. —2001.
— Vol. 60, № 1. — P. 52–57.165.Fernández-Llama P. Angiotensinogen gene M235T and T174M polymorphismsin essential hypertension. Relation with target organ damage / P. Fernández-Llama,E. Poch, J. Oriola [et al.]// Am. J. Hypertens. – 1998. – Vol. 11, № 4. – P. 439–444187166. Fox K.M. Efficacy of perindopril in reduction of cardiovascular events amongpatients with stable coronary artery disease: randomised, double–blind, placebo–controlled, multicentre trial (the EUROPA study) / K.M. Fox // Lancet. – 2003. –Vol. 362. – Р.782–788.167. FreitasS.R.Analysisofrennin-angiotensin-aldosteronesystemgenepolymorphisms resistant hypertension / S.R.
Freitas, P.H. Cabello, R. S. MouraNeto, L.C. Dolinsky [et al.] // Braz. J. Med. Biol. Res. –2007. – Vol. 40, №3. – P.309-316.168. Gerdts E. Impact of left ventricular geometry on prognosis in hypertensivepatients with left ventricular hypertrophy (the LIFE study) / E. Gerdts, D. Cramariuc,G. de Simone [et al.] // Eur. J. Echocardiogr. – 2008. – Vol.
9. – P. 809-815.169.Ghali J.K. Metoprolol CR / XL in Female Patients With Heart Failure Analysis ofthe Experience in Metoprolol Extended–Release Randomized Intervention Trial inHeart Failure (MERIT–HF)/ J.K. Ghali, I.L. Piсa, S.S. Gottlieb [et al.] //Circulation. – 2002. – Vol. 105. – Р.1585–1591.170. Glavnic N.М237Тpolymorphismoftheangiotensinogengeneandinsertion/deletion polymorphism of the angiotensinogen-I converting enzyme genein essential arterial hypertension in Caucasians / N. Glavnic, D. Petrovic // FoliaBiologica. (Praha). – 2007.
– Vol. 53, N 2. – P. 69–70.171. Goldbergova M. Association of two angiotensinogen gene polymorphisms,M235Y and G (–6) A, with chronic heart failure / M. Goldbergova, L. Spinarova, J.Spinar [et al.] // Int. J. Cardiology. – 2003. –Vol. 89, № 2–3. – P. 267–272.172. Hamelin B.A. Increased risk of myocardial infarction associated withangiotensin-converting enzyme gene polymorphism is age dependent / B.A.Hamelin, M.
Zakrzewski-Jakubiak, N.M. Robitaille, P. Bogaty [et al.] //J. Clin.Pharmacol. – 2011. – Vol. 51, № 9. – Р.1286-1292.173.Hamon M. Association of angiotensin converting enzyme and angiotensin II type1 receptor genotypes with left ventricular function and mass in patients withangiographically normal coronary arteries / M. Hamon, C. Amant, C. Bauters [et al.]// Heart. – 1997. – Vol.
77, № 6. – P. 502–505.188174.Hansson L. Effects of intensive blood–pressure lowering and low–dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) randomised trial. HOT Study Group / L. Hansson, A. Zanchetti, S.G.Carruthers [et al.] // Lancet. – 1998. – Vol. 351(9118). – P. 1755–1762.175. Hengstenberg C. Association between a polymorphism in the G protein b3subunit gene q (GNB3) with arterial hypertension but not with myocardial infarction/ C. Hengstenberg, H. Schunkert, B. Mayer, A. Doring [еt al.] //CardiovascularResearch. – 2001. – Vol. 49.
– P. 820–827.176. Herrmann S.M. Angiotensin II type 2 receptor gene polymorphism andcardiovascular phenotypes: the GLAECO and GLAOLD studies / S.M. Herrmann,V. Nicaud, K. Schmidt-Petersen [et al.] // Eur. J. Heart Fail. – 2002. – Vol. 4, № 6. –P. 707–712.177. Higashi Y. Endothelial function and oxidative stress in cardiovascular diseases /Y. Higashi, K.
Noma, M. Yoshizumi [et al.] // Circ. J. – 2009. – Vol. 73, № 3. – P.411–418.178. Huang P.H., Chen Y.H., Chen Y.L., Wu T.C. Vascular endothelial function andcirculating endothelial progenitor cells in patients with cardiac syndrome X// Heart.
2007. - № 93 (12). P. 1064-1070.179.Iio C. Association Between Genetic Variation in the SCN 10A Gene and CardiacConduction Abnormalities in Patients With Hypertrophic Cardiomyopathy / C. Iio,A. Ogimoto, T. Nagai [et al.] // J. Int. Heart J. – 2015. – Vol. 56 (4) – P. 421-427.180. Isaji M. Correlation between left ventricular mass and urinary sodium excretionin specific genotypes of CYP11B2 / M.
Isaji, T. Mune, N. Takada [et al.] // J.Hypertension. – 2005. – Vol. 23, № 6. – P. 1149–1157.181.Jamerson K., for ACCOMPLISH Trial Investigators. Benazepril plus amlodipinor hydrochlorthiazide for hypertension in high-risk patient / K. Jamerson, M.A.Weber, G.L. Bakris [et al.] // N. Engl. J. Med. – 2008. – Vol. 359.
– P. 2417-2426.182. Jeng J.R. Left ventricular mass, carotid wall thickness, and angiotensinogen genepolymorphism in patients with hypertension / J.R. Jeng // Am. J. Hypertens. – 1999.– Vol. 12, № 5. – P. 443–450.189183.Jeunemaitre X. Molecular basis of human hypertension: role of angiotensinogen /X. Jeunemaitre, F. Soubrier, Y.V. Kotelevtsev [et al.] // Cell. – 1992. – Vol. 71, № 1.– P. 169–180.184. Ji L.D. Association of angiotensinogen gene M235T and angiotensinconvertingenzyme gene I/D polymorphisms with essential hypertension in Han Chinesepopulation: a meta-analysis / L.D. Ji, L.N.
Zhang, P. Shen [et al.] //J. Hypertension.– 2010. – Vol. 28, № 3. – Р.419-428.185. Jones A. Genetic variants of angiotensin II receptors and cardiovascular risk inhypertension / A. Jones, S.S. Dhamrait, J.R. Payne [et al.] // Hypertension. – 2003. –№42 (4). – Р.500-506.186.Kanat O. Renin-angiotensin system polymorphisms and coronary artery surgerypatients / O.
Kanat // Asian cardiovascular thoracic annals. – 2005. – № 13(2). – P.153-156.187. Karen Tu. The Canadian Hypertension Education Program Outcomes ResearchTaskforce / Tu. Karen [et al.] // CMAJ. – 2008. – Vol.178, № 11. – P. 1436-1440.188.Kato N. G protein 3 subunit variant and essential hypertension in Japanese / N.Kato, T.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
